organization · Reporting owner
Corebridge DECO II, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
FRACTYL HEALTH, INC.
Report date February 06, 2024 · Filed February 08, 2024
Section 16 reporting ended · disclosed 2024-02-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 673,391 |
Reported balance
After 2024-02-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-02-06 · Conversion · Acquired 673,391 · Balance 673,391 F1: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F2: Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc. |
| Series E Preferred SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-02-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-02-06 · Conversion · Disposed 1,172,236 · Balance 0 F1: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F2: Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc. |
| Series F Preferred SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-02-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-02-06 · Conversion · Disposed 272,863 · Balance 0 F1: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F2: Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date.
F2: Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 06, 2024 Filed Feb 8, 2024 16:51 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries F Preferred Shares · Derivative | 272,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-012331 · tm245543-2_4seq1.xml · derivative · entry 3 Corebridge DECO II, LLC · CIK 0002010491 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 127,149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F1 · derivative.exercise_date: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F1 · derivative.expiration_date: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F2 · ownership.direct: Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:51 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries E Preferred Shares · Derivative | 1,172,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-012331 · tm245543-2_4seq1.xml · derivative · entry 2 Corebridge DECO II, LLC · CIK 0002010491 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 546,242 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F1 · derivative.exercise_date: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F1 · derivative.expiration_date: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F2 · ownership.direct: Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:51 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionCommon Stock | 673,391 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-012331 · tm245543-2_4seq1.xml · nonDerivative · entry 1 Corebridge DECO II, LLC · CIK 0002010491 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 673,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Series E Convertible Preferred Stock and Series F Convertible Preferred Stock (together, the "Preferred Shares") automatically converted into shares of the Issuer's common stock, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of common stock, at a conversion ratio of 1 share of Common Stock for 2.146 Preferred Shares. The Preferred Shares had no expiration date. F2 · ownership.direct: Corebridge DECO II, LLC is an indirect subsidiary of American International Group, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.